Patients should seek urgent medical attention if they experience: Severe or persistent abdominal pain (possible pancreatitis or gallbladder complication) Signs of dehydration (dizziness, reduced urine output) due to vomiting or diarrhoea Symptoms of hypoglycaemia (shakiness, sweating, confusion) or hyperglycaemia (excessive thirst, frequent urination) Severe headache or visual disturbance (possible raised intracranial pressure) Signs of an allergic reaction (rash, swelling, difficulty breathing) Regular monitoring should include fasting glucose, HbA1c, IGF-1, lipid panels, liver function, and renal function
All authors declare that there was no source of funding regarding this manuscript
It has become the latest food company to shake up its offering to cater to an American market where 30 million people have tried GLP-1 agonist drugs already, a number that could reach 100 million or 40% of the population in the coming years
Recent advances in targeting the undruggable proteins: from drug discovery to clinical trials
Can I take semaglutide one week and tirzepatide the next
Furthermore, semaglutides once-weekly administration could improve patient adherence to treatment
